Evaxion Biotech A/S (EVAX) Competitors

Evaxion Biotech A/S (NASDAQ:EVAX) and Cocrystal Pharma (NASDAQ:COCP) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, community ranking, risk, valuation, analyst recommendations, dividends, earnings and profitability.

Is EVAX or COCP more profitable?

Cocrystal Pharma has a net margin of 0.00% compared to Evaxion Biotech A/S's net margin of -347.83%. Evaxion Biotech A/S's return on equity of 0.00% beat Cocrystal Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evaxion Biotech A/S	-347.83%	N/A	-79.40%
Cocrystal Pharma	N/A	-94.62%	-78.24%

Does the MarketBeat Community prefer EVAX or COCP?

Evaxion Biotech A/S received 3 more outperform votes than Cocrystal Pharma when rated by MarketBeat users. However, 77.42% of users gave Cocrystal Pharma an outperform vote while only 67.50% of users gave Evaxion Biotech A/S an outperform vote.

Company	Underperform	Outperform
Evaxion Biotech A/S	Outperform Votes 27 67.50%	Underperform Votes 13 32.50%
Cocrystal Pharma	Outperform Votes 24 77.42%	Underperform Votes 7 22.58%

Do analysts rate EVAX or COCP?

Evaxion Biotech A/S currently has a consensus price target of $10.00, suggesting a potential upside of 255.87%. Cocrystal Pharma has a consensus price target of $7.00, suggesting a potential upside of 374.58%. Given Cocrystal Pharma's higher possible upside, analysts plainly believe Cocrystal Pharma is more favorable than Evaxion Biotech A/S.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evaxion Biotech A/S	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Cocrystal Pharma	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has better valuation & earnings, EVAX or COCP?

Cocrystal Pharma has lower revenue, but higher earnings than Evaxion Biotech A/S. Evaxion Biotech A/S is trading at a lower price-to-earnings ratio than Cocrystal Pharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evaxion Biotech A/S	$3.29M	1.20	-$22.12M	-$1.16	-2.42
Cocrystal Pharma	N/A	N/A	-$17.98M	-$1.57	-0.94

Do insiders & institutionals have more ownership in EVAX or COCP?

11.0% of Evaxion Biotech A/S shares are owned by institutional investors. Comparatively, 6.7% of Cocrystal Pharma shares are owned by institutional investors. 41.6% of Evaxion Biotech A/S shares are owned by insiders. Comparatively, 28.1% of Cocrystal Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more volatility and risk, EVAX or COCP?

Evaxion Biotech A/S has a beta of 0.1, suggesting that its stock price is 90% less volatile than the S&P 500. Comparatively, Cocrystal Pharma has a beta of 2.15, suggesting that its stock price is 115% more volatile than the S&P 500.

Does the media refer more to EVAX or COCP?

In the previous week, Cocrystal Pharma had 1 more articles in the media than Evaxion Biotech A/S. MarketBeat recorded 3 mentions for Cocrystal Pharma and 2 mentions for Evaxion Biotech A/S. Cocrystal Pharma's average media sentiment score of 0.57 beat Evaxion Biotech A/S's score of 0.43 indicating that Cocrystal Pharma is being referred to more favorably in the news media.

Company	Overall Sentiment
Evaxion Biotech A/S	Neutral
Cocrystal Pharma	Positive

Summary

Cocrystal Pharma beats Evaxion Biotech A/S on 9 of the 16 factors compared between the two stocks.